Search Results

There are 19861 results for: content related to: Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer

  1. Role of radiation therapy in the management of pancreatic cancer

    Journal of Surgical Oncology

    Volume 107, Issue 1, 1 January 2013, Pages: 86–96, Karyn A. Goodman and Carla Hajj

    Version of Record online : 24 APR 2012, DOI: 10.1002/jso.23137

  2. Intravesical gemcitabine for non-muscle invasive bladder cancer

    Intervention Review

    The Cochrane Library

    Gabriel Jones, Anne Cleves, Timothy J Wilt, Malcolm Mason, Howard G Kynaston and Mike Shelley

    Published Online : 18 JAN 2012, DOI: 10.1002/14651858.CD009294.pub2

  3. You have free access to this content
    Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review

    BJU International

    Volume 109, Issue 4, February 2012, Pages: 496–505, Mike D. Shelley, Gabriel Jones, Anne Cleves, Timothy J. Wilt, Malcolm D. Mason and Howard G. Kynaston

    Version of Record online : 7 FEB 2012, DOI: 10.1111/j.1464-410X.2011.10880.x

  4. Synthesis and characterization of saccharide-functionalized polymer–gemcitabine conjugates based on chemoenzymatic selective strategy

    Journal of Applied Polymer Science

    Volume 124, Issue 3, 5 May 2012, Pages: 1840–1847, Guo-Jun Zhou, Xia Li, Ming-Xing Teng, Guo-Hai Chu and Xian-Fu Lin

    Version of Record online : 21 OCT 2011, DOI: 10.1002/app.35201

  5. Validation of a hydrophilic interaction ultra-performance liquid chromatography–tandem mass spectrometry method for the determination of gemcitabine in human plasma with tetrahydrouridine

    Biomedical Chromatography

    Volume 29, Issue 9, September 2015, Pages: 1343–1349, Yuji Mano, Kenji Sakamaki, Takuya Ueno, Kenji Kita, Takuho Ishii, Koichiro Hotta and Kazutomi Kusano

    Version of Record online : 2 FEB 2015, DOI: 10.1002/bmc.3429

  6. You have free access to this content
    Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells

    The FEBS Journal

    Volume 279, Issue 7, April 2012, Pages: 1261–1273, Fu Li, Gang Hu, Zhenzhou Jiang, Jingjing Guo, Ke Wang, Kedong Ouyang, Danyi Wen, Minghua Zhu, Jiaxin Liang, Xiaoran Qin and Luyong Zhang

    Version of Record online : 12 MAR 2012, DOI: 10.1111/j.1742-4658.2012.08521.x

  7. Labeling, biodistribution and evaluation of [125I] gemcitabine: a potential agent for tumor diagnosis and radiotherapy

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 52, Issue 3, March 2009, Pages: 91–97, O. A. El-Kawy, A. M. Hashem, M. A. Amin and A. S. El-Wetery

    Version of Record online : 16 JAN 2009, DOI: 10.1002/jlcr.1573

  8. You have free access to this content
    Synthesis and Biological Evaluation of Oral Prodrugs Based on the Structure of Gemcitabine

    Chemical Biology & Drug Design

    Volume 80, Issue 3, September 2012, Pages: 479–488, Cuirong Zhao, Xiaoxia Xue, Gang Li, Cuicui Sun, Changjun Sun, Xianjun Qu and Wenbao Li

    Version of Record online : 25 JUN 2012, DOI: 10.1111/j.1747-0285.2012.01422.x

  9. Interstitial lung disease associated with gemcitabine: A Japanese retrospective cohort study

    Respirology

    Volume 21, Issue 2, February 2016, Pages: 338–343, Tsuyoshi Hamada, Hideo Yasunaga, Yousuke Nakai, Hiroyuki Isayama, Hiroki Matsui, Kiyohide Fushimi and Kazuhiko Koike

    Version of Record online : 2 NOV 2015, DOI: 10.1111/resp.12665

  10. Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue 2, March/April 2006, Pages: 507–514, C.J. POOLE, T. PERREN, S. GAWANDE, M. RIDDERHEIM, J. COOK, A. JENKINS and D. ROYCHOWDHURY

    Version of Record online : 25 APR 2006, DOI: 10.1111/j.1525-1438.2006.00466.x

  11. You have full text access to this OnlineOpen article
    Multidisciplinary neoadjuvant management for potentially curable pancreatic cancer

    Cancer Medicine

    Volume 4, Issue 8, August 2015, Pages: 1224–1239, Neelam V. Desai, Sarunas Sliesoraitis, Steven J. Hughes, Jose G. Trevino, Robert A. Zlotecki, Alison M. Ivey and Thomas J George Jr

    Version of Record online : 13 MAR 2015, DOI: 10.1002/cam4.444

  12. You have free access to this content
    Sequential chemoradiotherapy with gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma

    International Journal of Cancer

    Volume 132, Issue 1, 1 January 2013, Pages: 215–223, Mo-Fa Gu, Li-Zhi Liu, Long-Jun He, Wen-Xin Yuan, Rong Zhang, Guang-Yu Luo, Guo-Liang Xu, Hua-Man Zhang, Chao-Xian Yan and Jian-Jun Li

    Version of Record online : 13 JUN 2012, DOI: 10.1002/ijc.27638

  13. Ceramide metabolism determines glioma cell resistance to chemotherapy

    Journal of Cellular Physiology

    Volume 221, Issue 3, December 2009, Pages: 688–695, Claudia Alexandra Dumitru, Michael Weller and Erich Gulbins

    Version of Record online : 26 AUG 2009, DOI: 10.1002/jcp.21907

  14. Gemcitabine for unresectable, locally advanced or metastatic bladder cancer

    Intervention Review

    The Cochrane Library

    Mike Shelley, Anne Cleves, Timothy J Wilt and Malcolm Mason

    Published Online : 13 APR 2011, DOI: 10.1002/14651858.CD008976.pub2

  15. You have full text access to this OnlineOpen article
    Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 2, February 2015, Pages: 340–350, Yang Guo, Andreas Ziesch, Sandra Hocke, Eric Kampmann, Stephanie Ochs, Enrico N. De Toni, Burkhard Göke and Eike Gallmeier

    Version of Record online : 21 OCT 2014, DOI: 10.1111/jcmm.12444

  16. Advanced or Metastatic Pancreatic Cancer: Molecular Targeted Therapies

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 77, Issue 6, November/December 2010, Pages: 606–619, Soley Bayraktar and Caio M. Rocha-Lima

    Version of Record online : 23 NOV 2010, DOI: 10.1002/msj.20217

  17. Efficacy of a Poly-L-Glutamic Acid-Gemcitabine Conjugate in Tumor-Bearing Mice

    Drug Development Research

    Volume 73, Issue 3, May 2012, Pages: 120–129, Lik Voon Kiew, Soon Keng Cheong, Ernidila Ramli, Khalifah Sidik, Tuck Meng Lim and Lip Yong Chung

    Version of Record online : 7 MAY 2012, DOI: 10.1002/ddr.21012

  18. Primary Pancreatic Adenocarcinoma

    Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach

    Christopher L. Wolfgang, Timothy M. Pawlik, Ralph H. Hruban, Karen M. Horton, Elliot K. Fishman, Robert A. Meguid, Daniel Laheru, Joseph Herman, Manuel Hildago, Jeffrey Infante, Wells Messersmith, Pages: 498–542, 2009

    Published Online : 14 JAN 2009, DOI: 10.1002/9781444300147.ch21

  19. Development and validation of a stability indicating isocratic HPLC method for gemcitabine with application to drug release from poly lactic-co-glycolic acid nanoparticles and enzymatic degradation studies

    Journal of Pharmacy and Pharmacology

    Volume 67, Issue 11, November 2015, Pages: 1528–1536, Guanyu Chen, Darren Svirskis and Jingyuan Wen

    Version of Record online : 15 SEP 2015, DOI: 10.1111/jphp.12470

  20. You have full text access to this Open Access content
    RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells

    Journal of Cellular and Molecular Medicine

    Volume 12, Issue 6a, December 2008, Pages: 2334–2349, C. Yu, X. Zhang, G. Sun, X. Guo, H. Li, Y. You, J. L. Jacobs, K. Gardner, D. Yuan, Z. Xu, Q. Du, C. Dai, Z. Qian, K. Jiang, Y. Zhu, Q. Q. Li and Y. Miao

    Version of Record online : 6 FEB 2008, DOI: 10.1111/j.1582-4934.2008.00257.x